BENAFICA, LLC – Trademark Portfolio
Entity Type: 16
BENAFICA, LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 5 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include BENNGI and BENNGIHEALTH. The owner is based in ST. PAUL, MN.
6701 UPPER AFTON ROAD
ST. PAUL, MN 55125
Showing of trademarks Trademarks
Trademark Classifications
BENAFICA, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Insurance; financial affairs; monetary affairs; real estate affairs
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does BENAFICA, LLC have?
BENAFICA, LLC has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 cancelled.
What trademark classes does BENAFICA, LLC file in?
BENAFICA, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 36 (Insurance & Financial), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are BENAFICA, LLC's most well-known trademarks?
BENAFICA, LLC's registered trademark portfolio includes well-known marks such as BENNGI and BENNGIHEALTH. These are among 3 currently registered trademarks in the portfolio.
What is BENAFICA, LLC's trademark registration success rate?
BENAFICA, LLC has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.